EPIGEN Trademark

Trademark Overview

On Saturday, August 6, 2022, a trademark application was filed for EPIGEN with the United States Patent and Trademark Office. The USPTO has given the EPIGEN trademark a serial number of 97538218. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, January 7, 2025. This trademark is owned by Moniker Inc.. The EPIGEN trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Biomedical services, namely, medical testing for diagnostic or treatment purposes
epigen

General Information

Serial Number97538218
Word MarkEPIGEN
Filing DateSaturday, August 6, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, January 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2025

Trademark Statements

Goods and ServicesBiomedical services, namely, medical testing for diagnostic or treatment purposes

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, August 28, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMoniker Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92103
Party NameMoniker Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92103

Trademark Events

Event DateEvent Description
Wednesday, August 10, 2022NEW APPLICATION ENTERED
Sunday, August 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 24, 2023ASSIGNED TO EXAMINER
Monday, June 5, 2023NON-FINAL ACTION WRITTEN
Monday, June 5, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 5, 2023NON-FINAL ACTION E-MAILED
Tuesday, September 5, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, September 5, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, December 4, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 4, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 6, 2023SUSPENSION LETTER WRITTEN
Wednesday, December 6, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, December 6, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, October 22, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 28, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, January 1, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 7, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 7, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

epigen diagnostic treatment purposes testing medical services namely biomedical